56 results
Page 2 of 3
8-K
EX-99.1
5qv8dkgwq
10 May 22
Satsuma Pharmaceuticals Reports First Quarter 2022 Financial Results
4:02pm
8-K
EX-99.1
e4x0 t9ju
15 Mar 22
Satsuma Pharmaceuticals Reports 2021 Full Year and Fourth Quarter Financial Results and Business Highlights
4:40pm
8-K
EX-99.1
o1gpwjgak9m4369wxccn
9 Nov 21
Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results
5:00pm
8-K
EX-99.1
ihzbj
10 Aug 21
Satsuma Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:01pm
8-K
EX-99.1
d17sh91g u9ln
16 Jun 21
Satsuma Pharmaceuticals Announces Positive Pharmacokinetic, Tolerability and Safety Results From Phase 1 Trial of STS101 at Multiple Dose Strengths
4:29pm
8-K
EX-99.1
wyi xg9pn58
11 May 21
Satsuma Pharmaceuticals Reports First Quarter 2021 Financial Results
4:05pm
8-K
EX-99.1
d6dgwyyc
25 Mar 21
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
5:02pm
8-K
EX-99.2
pz2sj3oy06l67wn2
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
8-K
EX-99.1
2dsnd77 kv
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
8-K
EX-99.1
nb524vmghqyx5pvkb 52
10 Nov 20
Satsuma Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results
4:21pm
S-3
EX-1.2
gsgr9sol8px8ix9
23 Oct 20
Shelf registration
4:48pm